(Q40197990)
Statements
1 reference
A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma (English)
1 reference
Chuanying Geng
1 reference
Jian Hou
1 reference
Yaozhong Zhao
1 reference
Xiaoyan Ke
1 reference
Zhao Wang
1 reference
Lugui Qiu
1 reference
Hao Xi
1 reference
Fuxu Wang
1 reference
Na Wei
1 reference
Yan Liu
1 reference
Shifang Yang
1 reference
Peng Wei
1 reference
Xiangjun Zheng
1 reference
Zhongxia Huang
1 reference
Bing Zhu
1 reference
Wen-Ming Chen
1 reference
29 September 2014
1 reference
1 reference
89
1 reference
11
1 reference
1037-1042
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference